We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.EX-10.1 2 dex101.htm LICENSE AGREEMENTLicense Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 Jurisdiction*** CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST UNDER 17 C.F.R. SECTIONS 200.80(B)(4) AND 230.406.
LICENSE AGREEMENT by and between ORTHOVITA, INC. and ANGIOTECH PHARMACEUTICALS (US), INC. dated March 20, 2006 (Effective January 1, 2006)License Agreement • May 10th, 2006 • Orthovita Inc • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 10th, 2006 Company Industry JurisdictionTHIS LICENSE AGREEMENT (“Agreement”) is executed as of March 20, 2006 by and between Orthovita, Inc., a Pennsylvania corporation with principal offices at 45 Great Valley Parkway, Malvern, Pennsylvania 19355 (“Orthovita”), and Angiotech Pharmaceuticals (US), Inc., a Delaware corporation with principal offices at 101 W. North Bend Way, Suite 201, PO Box 2840, North Bend, WA 98045 (“Angiotech”).